- Home
- EPSM vs PDSB Comparison
EPSM vs PDSB Comparison
Compare EPSM & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPSM
- PDSB
- Stock Information
- Founded
- EPSM 2010
- PDSB 2005
- Country
- EPSM China
- PDSB United States
- Employees
- EPSM N/A
- PDSB N/A
- Industry
- EPSM
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- EPSM
- PDSB Health Care
- Exchange
- EPSM Nasdaq
- PDSB Nasdaq
- Market Cap
- EPSM 71.3M
- PDSB 58.7M
- IPO Year
- EPSM 2025
- PDSB N/A
- Fundamental
- Price
- EPSM $4.95
- PDSB $1.16
- Analyst Decision
- EPSM
- PDSB Strong Buy
- Analyst Count
- EPSM 0
- PDSB 3
- Target Price
- EPSM N/A
- PDSB $10.00
- AVG Volume (30 Days)
- EPSM 577.3K
- PDSB 794.1K
- Earning Date
- EPSM 01-01-0001
- PDSB 03-27-2025
- Dividend Yield
- EPSM N/A
- PDSB N/A
- EPS Growth
- EPSM N/A
- PDSB N/A
- EPS
- EPSM 0.05
- PDSB N/A
- Revenue
- EPSM $17,906,283.00
- PDSB N/A
- Revenue This Year
- EPSM N/A
- PDSB $5,518.68
- Revenue Next Year
- EPSM N/A
- PDSB N/A
- P/E Ratio
- EPSM $94.28
- PDSB N/A
- Revenue Growth
- EPSM N/A
- PDSB N/A
- 52 Week Low
- EPSM $4.23
- PDSB $1.05
- 52 Week High
- EPSM $6.34
- PDSB $4.42
- Technical
- Relative Strength Index (RSI)
- EPSM N/A
- PDSB 40.47
- Support Level
- EPSM N/A
- PDSB $1.19
- Resistance Level
- EPSM N/A
- PDSB $1.41
- Average True Range (ATR)
- EPSM 0.00
- PDSB 0.10
- MACD
- EPSM 0.00
- PDSB -0.01
- Stochastic Oscillator
- EPSM 0.00
- PDSB 27.63
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.